Member of the board since 2023
MSc in Microbiology from Gothenburg Univeristy,
Executive Faculty, Handelshögskolan Göteborg 2018
Ruter Dam 2022
Karen From has more than 25 years of experience in the pharmaceutical industry. She has worked at AstraZeneca since 1997 and has experience in both early and late development projects, in-licensing, regulatory interactions and launching large products. Since 2019, she is the Global Franchise Head for Forxiga, which is AstraZeneca’s second largest product with indications in diabetes, heart failure and kidney failure. In this role, she is globally responsible for the strategic leadership of development, commercialization, and production.
Styrelseledamot Bergsbo PF
No shares or warrants
Independent of the Company, its senior executives, and major shareholders